SAM
JAZZ icon

Smartleaf Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Smartleaf Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.1K Sell
219
-6
-3% -$1.05K ﹤0.01% 1578
2025
Q4 		$38.4K Buy
225
+53
+31% +$8.13K ﹤0.01% 1680
2025
Q3 		$22.2K Buy
172
+95
+123% +$11.4K ﹤0.01% 1777
2025
Q2 		$8.23K Sell
77
-47
-38% -$5.11K ﹤0.01% 1893
2025
Q1 		$15.2K Buy
124
+10
+9% +$1.3K ﹤0.01% 1745
2024
Q4 		$14K Buy
114
+56
+97% +$6.6K ﹤0.01% 1847
2024
Q3 		$6.43K Buy
58
+45
+346% +$4.93K ﹤0.01% 2002
2024
Q2 		$1.39K Buy
13
+4
+44% +$440 ﹤0.01% 2336
2024
Q1 		$1.08K Buy
+9
New +$1.1K ﹤0.01% 1610

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Smartleaf Asset Management's JAZZ Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.7% in Q1 2026, selling an estimated $1.05K and leaving 219 shares worth $40.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1578.

Smartleaf Asset Management first reported a position in JAZZ in Q1 2024 and has held it in 9 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Smartleaf Asset Management held 219 shares of Jazz Pharmaceuticals worth $40.1K as of Q1 2026.
  • Smartleaf Asset Management sold 6 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.05K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1578 holding.
  • Smartleaf Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.